TrialNature medicine2026

Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial.

Jan-Jaap J Mellema et al.PubMed ↗Publisher ↗

No numbers read from the abstract.